Stephen Strickland Jr, MD, MSCI, Director, Leukemia Research for Sarah Cannon Research Institute (SCRI)
Advertisement
Articles by Stephen Strickland Jr, MD, MSCI, Director, Leukemia Research for Sarah Cannon Research Institute (SCRI)
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
Mocertatug Rezetecan Drives Rapid, Deep Responses in Platinum-Resistant Ovarian and Recurrent/Advanced Endometrial Cancer
2
Iza-Bren Improves Survival in Unresectable, Locally Advanced or Metastatic TNBC
3
Trastuzumab Pamirtecan Provides Meaningful Survival Benefit in Pretreated HER2-Expressing Endometrial Cancer
4
Zongertinib, Sevabertinib Reshape Treatment Landscape for Patients With HER2-Mutated NSCLC
5